POET Stock Analysis: POET Technologies | NASDAQ
Semiconductors | NASDAQ, USA | Market Cap: 1.483m USD | 12M Return: 88.2% | CA73044W3021 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 97.0M
Qual. Beats: -3
Rev. Trend: 10.9%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality
POET Technologies Inc. is a Canadian-headquartered semiconductor company that designs, develops, manufactures, and sells photonic integrated packaging solutions based on its proprietary POET Optical Interposer platform. The technology enables the integration of electronic and photonic devices onto a single chip using wafer-level semiconductor manufacturing techniques. The company was formerly known as Opel Technologies Inc. before adopting its current name in June 2013, and it is listed on NASDAQ under the ticker POET.
The companys product portfolio includes photonic integrated circuits, optical engines, optical transceiver modules, and light source products. It serves a diverse set of end markets, including data center AI infrastructure, telecommunications (including 5G networks such as PON and GPON), edge computing for machine-to-machine communications, and sensing applications such as LIDAR, Optical Coherence Tomography for medical devices, and virtual reality systems. POET has a strategic collaboration with Lumilens Inc. focused on developing wafer-level photonic integration for AI optical networks.
POET operates globally, with commercial reach spanning North and South America, Europe, Malaysia, Singapore, China, and other parts of Asia. Photonic integration is a sub-segment of the broader semiconductor industry that uses light-based signal transmission instead of purely electrical signals, which is increasingly relevant to data center and AI workloads that demand high bandwidth and energy efficiency. Wafer-level semiconductor manufacturing refers to processing multiple chips simultaneously on a single wafer, a standard approach used to scale production and reduce per-unit costs in the chip industry.
- AI data center demand drives optical interposer order growth
- Strategic Lumilens partnership accelerates AI photonic integration roadmap
- Capital raises and dilution risk persist as R&D spending outpaces revenue
| Net Income: -81.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.08 > 0.02 and ΔFCF/TA 46.45 > 1.0 |
| NWC/Revenue: 20.3k% < 20% (prev 9.41k%; Δ 10.9k% < -1%) |
| CFO/TA -0.07 > 3% & CFO -30.9m > Net Income -81.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 3.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (147.5m) vs 12m ago 88.55% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 0.54% > 50% (prev 0.31%; Δ 0.23% > 0%) |
| Interest Coverage Ratio: -514.8 > 6 (EBIT TTM -81.5m / Interest Expense TTM 158k) |
| A: 0.62 (Total Current Assets 431.0m - Total Current Liabilities 143.8m) / Total Assets 461.8m |
| B: -0.67 (Retained Earnings -309.4m / Total Assets 461.8m) |
| C: -0.31 (EBIT TTM -81.5m / Avg Total Assets 263.3m) |
| D: 34.17 (Book Value of Equity 448.6m / Total Liabilities 13.1m) |
| Altman-Z'' = 35.70 = AAA |
| DSRI: 0.10 (Receivables 290k/1.29m, Revenue 1.41m/199k) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 3.20 (AQ_t 0.03 / AQ_t-1 0.01) |
| SGI: 7.08 (Revenue 1.41m / 199k) |
| TATA: -0.11 (NI -81.6m - CFO -30.9m) / TA 461.8m) |
| Beneish M = 1.88 (Cap -4..+1) = D |
As of August 16, 2026, the stock is trading at USD 9.58 with a total of 15,958,834 shares traded. Over the past week, the price has changed by +7.52%, over one month by +8.74%, over three months by -53.43% and over the past year by +88.21%.
Current recommended Stop Loss: 8.70 (which is 9.2% or 1.1 ATR below the current price).
POET Technologies has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy POET.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 17.5 | 82.7% |
P/S = 1050.3396
P/B = 3.293
Revenue TTM = 1.41m USD
EBIT TTM = -81.5m USD
EBITDA TTM = -77.9m USD
Long Term Debt = 955k USD (estimated: total debt 7.02m - short term 6.07m)
Short Term Debt = 6.07m USD (from shortTermDebt, last quarter)
Debt = 8.24m USD (from shortLongTermDebtTotal, last quarter) + Leases 1.22m
Net Debt = -420.9m USD (calculated: Debt 8.24m - CCE 429.1m)
Enterprise Value = 1.06b USD (1.48b + Debt 8.24m - CCE 429.1m)
Interest Coverage Ratio = -514.8 (Ebit TTM -81.5m / Interest Expense TTM 158k)
EV/FCF = -30.23x (Enterprise Value 1.06b / FCF TTM -35.1m)
FCF Yield = -3.31% (FCF TTM -35.1m / Enterprise Value 1.06b)
FCF Margin = -2.49k% (FCF TTM -35.1m / Revenue TTM 1.41m)
Net Margin = -5.78k% (Net Income TTM -81.6m / Revenue TTM 1.41m)
Gross Margin = unknown ((Revenue TTM 1.41m - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 2.30 (Enterprise Value 1.06b / Total Assets 461.8m)
Interest Expense / Debt = 1.92% (Interest Expense 158k / Debt 8.24m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -64.4m (EBIT -81.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.00 (Total Current Assets 431.0m / Total Current Liabilities 143.8m)
Debt / Equity = 0.02 (Debt 8.24m / totalStockholderEquity, last quarter 448.6m)
Debt / EBITDA = 5.40 (negative EBITDA) (Net Debt -420.9m / EBITDA -77.9m)
Debt / FCF = 11.98 (negative FCF - burning cash) (Net Debt -420.9m / FCF TTM -35.1m)
Total Stockholder Equity = 187.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -31.01% (Net Income -81.6m / Total Assets 461.8m)
RoE = -43.65% (Net Income TTM -81.6m / Total Stockholder Equity 187.1m)
RoCE = -43.34% (EBIT -81.5m / Capital Employed (Equity 187.1m + L.T.Debt 955k))
RoIC = -14.13% (negative operating profit) (NOPAT -64.4m / Invested Capital 455.6m)
WACC = 20.13% (E(1.48b)/V(1.49b) * Re(20.23%) + D(8.24m)/V(1.49b) * Rd(1.92%) * (1-Tc(0.21)))
Discount Rate = 20.23% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 91.11 | Cagr: 74.62%
[DCF] Fair Price = unknown (Cash Flow -35.1m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -1.24 | # QB: -3
Revenue Correlation: 10.88 | Revenue CAGR: 12.99% | SUE: 0.68 | # QB: 0
EPS current Quarter (2026-09-30): EPS=-0.06 | Chg30d=-50.00% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=-0.24 | Chg30d=-60.00% | Revisions=+25% | GrowthEPS=+40.3% | GrowthRev=+826.7%
EPS next Year (2027-12-31): EPS=-0.17 | Chg30d=N/A | Revisions=-25% | GrowthEPS=+29.2% | GrowthRev=+894.7%